background
infant
toddler
children
primaryschool
age
without
special
risk
factor
gener
three
ten
febril
respiratori
infect
per
year
infect
viral
origin
selflimit
viral
infect
often
hard
distinguish
bacteri
infect
use
multiplex
polymeras
chain
reaction
pcr
detect
virus
respiratori
secret
potenti
benefici
might
help
physician
avoid
give
antibiot
unnecessarili
method
articl
base
select
review
literatur
find
author
investig
result
multiplex
pcr
highli
sensit
highli
specif
test
detect
viral
nucleic
acid
respiratori
secret
pcr
reveal
presenc
rna
deriv
respiratori
syncyti
viru
human
metapneumoviru
parainfluenza
viru
influenza
viru
acut
infect
caus
correspond
pathogen
probabl
present
treatment
given
accordingli
hand
nucleic
acid
adeno
boca
rhinoor
coronavirus
found
rel
trivial
infect
well
asymptomat
person
probabl
reflect
either
prior
infect
current
subclin
one
children
particular
upper
respiratori
infect
common
winter
month
acut
prior
infect
pathogen
distinguish
multiplex
pcr
use
multiplex
pcr
children
shown
shorten
hospit
stay
lessen
antibiot
consumpt
overal
cost
conclus
detect
viral
nucleic
acid
import
contribut
diagnost
assess
children
sever
respiratori
infect
highli
sensit
diagnost
test
use
optim
primari
viral
infect
must
distinguish
bacteri
superinfect
kraus
jc
pan
hengel
h
hennek
p
role
multiplex
pcr
respiratori
tract
infect
children
nfection
respiratori
tract
common
problem
first
decad
life
yearli
preval
respiratori
tract
infect
otherwis
healthi
old
child
three
infect
although
becom
accept
fact
among
pediatrician
gener
practition
respiratori
tract
infect
gener
selflimit
use
antibiot
indic
germani
high
time
period
month
one
third
children
adolesc
younger
year
age
take
antibiot
common
pathogen
caus
bacteri
pneumonia
childhoodstreptococcu
pneumonia
haemophilu
influenzaear
part
nasopharyng
mucos
flora
healthi
children
confirm
viral
infect
use
tradit
methodsvir
cultur
direct
immunofluoresc
test
rapid
antigen
testsar
mani
case
labori
unreli
direct
immunofluoresc
test
rapid
antigen
test
yield
result
within
hour
mani
case
lack
sensit
specif
avail
virus
serolog
test
unsuit
diagnost
evalu
acut
respiratori
infect
respiratori
tract
infect
caus
clinic
multitud
pathogen
pathogenspecif
clinic
symptom
often
lack
view
potenti
pathogen
investig
use
specif
polymeras
chain
reaction
pcr
individu
virus
monoplexpcr
soon
timeconsum
elabor
laboratori
multiplexpcr
method
enabl
test
mani
pathogen
parallel
singl
analysi
therefor
increasingli
gain
import
sinc
requir
specimen
volum
time
expens
cost
expenditur
hardli
differ
monoplexpcr
even
though
differ
pathogen
analyz
simultan
review
articl
restrict
multiplexpcr
aim
summar
current
research
statu
multiplexpcr
clinician
treat
pediatr
outpati
inpati
result
current
avail
commerci
multiplex
method
avail
within
one
six
hour
depend
pathogen
investig
confirm
viral
bacteri
nucleic
acid
howev
enabl
conclus
regard
pathogen
abil
multipli
infect
gener
analyt
sensit
specif
multiplexpcr
becom
quit
similar
monoplexpcr
howev
studi
shown
lower
sensit
individu
pathogensfor
exampl
respiratori
syncyti
viru
rsv
human
metapneumoviru
hmpv
enterovirus
technolog
differ
test
format
exist
date
quantit
conclus
reliabl
establish
neither
monoplexpcr
multiplexpcr
test
use
confirm
virus
also
bacteria
mycoplasma
pneumonia
bordetella
pertussi
set
multiplexpcr
sampl
transport
specimen
also
major
import
suitabl
specimen
confirm
respiratori
pathogen
obtain
upper
lower
respiratori
tractthat
nasopharyng
aspir
pharyng
swab
nasopharyng
swab
bronchoalveolar
lavag
fluid
confirm
frequenc
pathogen
children
acut
respiratori
symptom
may
excess
adult
notabl
lower
studi
one
reason
may
fact
children
much
higher
viral
titer
furthermor
view
fact
respiratori
tract
infect
children
occur
close
success
winter
season
assum
infect
actual
overlap
may
provid
explan
fact
viral
nucleic
acid
differ
virus
one
specimen
found
virtual
childrenfor
exampl
specimen
analyz
author
articl
tabl
summar
taxonom
characterist
typic
diseas
pattern
specif
treatment
select
respiratori
virus
sinc
clinic
symptom
respiratori
tract
infect
children
similar
one
anoth
structur
follow
section
accord
symptom
pathogen
addit
benefit
individu
patient
use
multiplexpcr
advantag
perspect
hospit
hygien
enough
singl
room
patient
group
accord
clinic
symptom
advantag
put
togeth
cohort
pathogen
plausibl
recommend
rsv
influenzavirus
robert
kochinstitut
rki
even
studi
suffici
confirm
respiratori
syncyti
viru
rsv
paramyxoviru
common
caus
bronchiol
pneumonia
first
year
life
children
younger
month
treat
rsv
inpati
us
studi
furthermor
rsv
caus
apnea
neonat
young
infant
even
patient
receiv
prophylact
treatment
palivizumab
first
year
life
rsv
associ
death
influenza
death
v
death
per
personyear
bronchiol
clinic
diagnosi
respiratori
failur
obstruct
small
airway
mani
studi
author
recommend
refrain
routin
diagnost
evalu
exampl
microbiolog
test
radiographi
thorax
blood
ga
analys
children
bronchiol
sinc
impos
physic
stress
lead
unnecessari
inpati
admiss
treatment
recommend
partli
adher
germanspeak
countri
small
infant
virolog
diagnosi
contribut
avoid
investig
suspect
rsv
rapid
antigen
test
sensibl
first
step
high
specif
rapid
test
rsv
diagnosi
regard
confirm
result
posit
report
sensit
higher
nasopharyng
lavag
nasopharyng
swab
serum
plasma
suitabl
infant
young
toddler
becam
ill
rsv
season
diagnost
valid
found
notabl
higher
older
case
report
case
report
month
old
boy
present
emerg
outpati
depart
cough
fever
week
blood
count
show
leukocytosi
gl
neutrophilia
opacif
right
middl
lobe
radiolog
visibl
multiplexpcr
test
respiratori
pathogen
nasopharyng
secret
yield
posit
result
human
metapneumoviru
hmpv
boy
high
temperatur
pronounc
leukocytosi
neutrophilia
lobar
opacif
thorac
xray
film
howev
rais
urgent
suspicion
bacteri
superinfect
reason
intraven
ampicillin
treatment
start
blood
cultur
show
group
streptococci
diseas
cours
case
report
weekold
babi
girl
born
term
present
fever
cough
decreas
oral
intak
two
day
somnol
brighten
given
antipyrrhet
leukocyt
count
normal
rang
gl
without
left
shift
blood
smear
babi
urin
statu
normal
pulmonari
infiltr
seen
radiolog
multiplexpcr
nasopharyng
secret
confirm
influenza
child
admit
night
close
monitor
discharg
home
follow
day
improv
gener
condit
without
antibiot
treatment
children
outsid
rsv
season
case
rsv
infect
acut
suspect
rapid
rsv
test
yield
neg
result
rsvpcr
subsequ
undertaken
sinc
bronchiol
also
caus
number
pathogen
exampl
hmpv
multiplexpcr
undertaken
case
coinfect
rsv
respiratori
virus
common
increas
sever
diseas
coinfect
rsv
bordetella
pertussi
also
observ
lobar
pneumonia
due
staphylococcu
aureu
streptococcu
pneumonia
wellknown
complic
rsv
infect
children
use
healthcar
servic
everi
year
influenza
addit
mani
case
infect
influenzaviru
diagnos
larg
us
studi
inpati
outpati
influenza
test
pathogen
us
everi
flu
season
death
per
children
adolesc
half
children
die
flu
wellknown
risk
factor
chronic
heart
diseas
chronic
lung
diseas
exampl
asthma
cystic
fibrosi
metabol
diseas
exampl
diabet
mellitu
immunodefici
neurolog
neuromuscular
disord
obes
pregnanc
flu
suspect
rapid
antigen
test
perform
first
step
result
neg
diagnost
evalu
mean
pcr
test
make
sens
earli
confirm
influenzavirus
help
treatment
neuraminidas
inhibitor
becom
option
oseltamivir
commonli
use
neuraminidas
inhibitor
howev
best
moder
effect
patient
immunosuppress
exampl
congenit
immunodefici
underli
oncolog
disord
patient
acut
pulmonari
deterior
cystic
fibrosi
may
also
benefit
stringent
flu
diagnost
patient
indic
neuraminidas
inhibitor
could
also
justifi
defin
gener
confirm
influenza
rna
obvious
rule
superinfect
pneumococci
staphylococci
h
influenza
case
pneumococc
pneumonia
associ
flu
proport
even
higher
time
increas
flu
activ
six
differ
human
pathogen
coronaviru
speci
hcov
known
date
discov
earli
rule
caus
benign
disord
upper
respiratori
tract
sar
epidem
sar
sever
acut
respiratori
syndrom
sarscov
describ
middl
eastern
respiratori
syndrom
mer
caus
merscov
multiplexpcr
method
use
differenti
assum
import
caus
nondiphther
croup
furthermor
coronavirus
also
caus
febril
convuls
patient
medic
histori
give
rise
suspicion
merscov
specif
diagnost
method
undertaken
robert
kochinstitut
refer
laboratori
univers
bonn
long
time
assum
symptomat
infect
respiratori
tract
virus
regularli
shown
confirm
viral
nucleic
acid
respiratori
secret
howev
recent
year
increas
indic
necessarili
case
bocavirus
constitut
exampl
clinic
import
human
parvovirus
discov
remain
subject
controversi
bocaviru
dna
confirm
respiratori
tract
even
asymptomat
children
high
concentr
virus
respiratori
specimen
seem
associ
symptom
quantit
monoplexpcr
multiplexpcr
usual
avail
provid
inform
viru
concentr
adenoviru
dna
also
often
found
respiratori
secret
asymptomat
children
reason
confirm
adenoviru
dna
exclud
kawasaki
diseas
children
kawasaki
diseas
adenovirus
confirm
lower
viru
concentr
children
symptomat
adenoviru
infect
furthermor
nucleic
acid
rhinovirus
coronavirus
persist
week
month
observ
particularli
hypogammaglobulinemia
rhinovirus
often
present
tumor
patient
patient
stem
cell
transplant
seem
associ
increas
mortal
patient
benefit
confirm
specif
pathogen
certain
patient
popul
oseltamivir
infanc
licenceapprov
europ
pandem
flu
outbreak
flu
rsv
acut
suspect
rapid
antigen
test
undertaken
first
result
avail
immedi
test
less
expens
pcrbase
diagnost
evalu
test
neg
author
current
articl
follow
multiplexpcr
hmpv
human
metapneumoviru
rsv
human
respiratori
synciti
viru
chronic
cardiac
pulmonari
disord
metabol
disord
exampl
diabet
mellitu
immunodefici
neurolog
neuromuscular
disord
obes
pregnanc
sever
immunosuppress
patient
sever
cours
like
also
hmpv
adenovirus
coplasma
studi
summer
examin
patient
treat
inpati
basi
author
experi
confirm
mycoplasma
nucleic
acid
dna
atyp
pathogen
respiratori
secret
use
multiplexpcr
except
also
remain
subject
controversi
whether
treatment
mycoplasma
pneumonia
antibiot
benefici
anoth
atyp
respiratori
pathogen
chlamydophila
pneumonia
found
rare
case
childhood
pneumonia
robert
kochinstitut
regard
pcr
gold
standard
diagnost
evalu
chlamydophila
pneumonia
fewer
infect
legionella
spp
manifest
childhood
adolesc
overwhelmingli
first
year
life
teenag
robert
kochinstitut
attest
extraordinarili
high
sensit
pcr
techniqu
confirm
legionella
bacteria
respiratori
secret
tissu
even
though
cultur
still
regard
gold
standard
sensit
wide
use
rapid
urin
antigen
test
depend
sever
diseas
serotyp
especi
infant
acut
risk
apnea
caus
pertussi
multiplexpcr
allow
substanti
inform
advantag
compar
less
sensit
cultur
furthermor
method
also
captur
pathogen
caus
paroxysm
cough
studi
investig
cost
antibiot
usag
use
multiplexpcr
respiratori
pathogen
far
benefit
found
diagnost
techniqu
children
without
risk
factor
potenti
import
rate
excret
viral
nucleic
acid
specif
pathogen
directli
associ
acut
ill
present
problem
set
gener
multiplexpcr
use
whenev
consequ
treatment
resultfor
exampl
stop
cours
antibiot
treatment
far
algorithm
approach
valid
practic
author
recommend
use
multiplexpcr
especi
first
month
life
children
risk
factor
influenza
immunosuppress
patient
exampl
patient
undergon
allogen
stem
cell
transplant
clinic
consequ
like
conclud
result
patient
tabl
infect
adenovirus
parainfluenza
virus
rsv
often
take
sever
cours
patient
undergon
allogen
stem
cell
transplant
studi
role
molecular
pathogen
diagnost
evalu
prevent
detect
nosocomi
chain
infect
hygien
indic
treat
specif
group
patient
exampl
cancer
patient
urgent
need
confirm
dna
hmpv
influenzaviru
parainfluenza
viru
rsv
enabl
conclus
caus
pathogen
molecular
confirm
four
pathogen
alway
rais
suspicion
infect
distant
past
may
directli
relat
patient
current
symptom
fact
import
especi
small
children
sinc
contract
multipl
infect
one
winter
season
short
latenc
period
episod
ill
rhedin
et
al
show
nucleic
acid
rsv
hmpv
parainfluenza
viru
confirm
almost
exclus
symptomat
children
rare
asymptomat
children
causal
associ
respiratori
tract
symptom
confirm
rsv
hmpv
parainfluenza
viru
therefor
seem
like
studi
rhinoviru
dna
confirm
symptomat
children
also
control
group
question
whether
routin
virolog
diagnost
evalu
base
antigen
confirm
pcr
reduc
antibiot
consumpt
pediatr
emerg
set
remain
unansw
cochran
metaanalysi
sinc
studi
suffici
larg
number
case
lack
oosterheert
et
al
show
confirm
rate
infect
lower
respiratori
tract
adult
increas
quantit
pcr
respiratori
pathogen
use
rather
convent
diagnost
test
howev
studi
show
reduct
antibiot
cost
one
limit
studi
fact
date
back
cost
incur
pcr
diagnost
eurospecimen
notabl
reduc
sinc
wishaupt
et
al
use
pcr
diagnost
differ
pathogen
context
control
studi
patient
younger
year
respiratori
tract
symptom
intervent
group
clinician
told
result
within
hour
specimen
taken
control
group
done
four
week
rsv
common
pathogen
averag
length
hospit
stay
durat
antibiot
therapi
differ
group
intervent
group
howev
show
significantli
higher
use
antibiot
reason
effect
remain
unclear
decis
favor
intraven
antibiot
made
basi
clinic
assess
pcr
result
known
sinc
studyand
similar
onesexclud
children
underli
diseas
particip
result
appli
children
previous
healthi
import
observ
studi
children
infect
upper
respiratori
tract
conduct
rotterdam
publish
plo
medicin
spuesen
et
al
found
mycoplasma
pneumonia
asymptomat
children
symptomat
children
interestingli
mycoplasma
persist
four
month
preval
myin
qualit
revers
transcriptasepcr
evalu
confirm
pathogensfor
exampl
bocavirus
rhinovirus
adenovirus
coronavirusesa
clinic
evalu
hope
aid
quantit
pcr
techniqu
futur
need
order
distinguish
acut
infect
subclin
event
nucleic
acid
persist
quantit
multiplexpcr
test
respiratori
secret
highli
sensit
method
diagnosi
respiratori
tract
infect
addit
viral
pathogen
atyp
bacteri
pathogen
also
confirm
confirm
nucleic
acid
influenzaviru
parainfluenza
viru
rsv
hmpv
usual
allow
conclus
acut
viral
infect
present
nucleic
acid
bocavirus
adenovirus
rhinovirus
coronavirus
often
found
asymptomat
person
quantit
measur
studi
viru
concentr
time
might
futur
contribut
distinguish
acut
infect
protract
nucleic
acid
excret
date
known
whether
use
multiplexpcr
reduc
length
inpati
stay
cost
inpati
treatment
administr
antibiot
especi
studi
nucleic
acid
confirm
guid
cohortform
children
respiratori
tract
infect
special
patient
popul
exampl
cancer
patient
immunosuppress
patient
patient
cystic
fibrosi
lack
